Health ❯ Healthcare ❯ Clinical Trials

Drug Trials

Eli Lilly Trials Epcoritamab Phase 1b Trials PATHFNDR Trials Fenebrutinib Ambroxol Weight Loss Drugs Pembrolizumab Cancer Research Phase 3 Trials

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Durable results are pushing doctors to start the drug first.

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

KOMET-007 Shows 600 mg Ziftomenib Plus Venetoclax/Azacitidine Achieves Deep Remissions in NPM1‑Mutated AML

Roche’s Oral BTK Drug Succeeds in Phase 3 MS Trials, Matching Ocrevus in Progressive Disease

Cannabis-Inspired Drug Shows Weight Gain in Small Cancer Cachexia Trial

Niraparib Add-On Slows Progression in Advanced Prostate Cancer, Phase III Trial Shows

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

Chemotherapy-Free Regimen Shows 94% Progression-Free Survival in CLL Trial

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

Keynote-689 Trial Finds Pembrolizumab Doubles Disease-Free Survival in Head and Neck Cancer

Breast Cancer Drugs Show Promise for Rare Bile Duct Cancer